SLU-PP-332 is a research peptide, also known as SLOOP, that acts as an exercise mimetic, activating estrogen-related receptors (ERRs) to boost mitochondrial function, increase energy production, and improve fat burning, essentially mimicking the benefits of physical activity at a cellular level. It's an oral compound showing promise in preclinical studies for enhancing metabolism, supporting lean muscle, aiding weight loss, and accelerating muscle repair by activating satellite cells, though human trials are limited.
How It Works
Activates ERRs:
It's a selective agonist for ERRα, a key protein in energy metabolism.
Boosts Mitochondria:
Promotes mitochondrial biogenesis (creating more mitochondria) and improves their efficiency, increasing the body's "horsepower".
Enhances Fat Burning:
Increases fatty acid oxidation, leading the body to burn stored fat for fuel.
Supports Muscle:
Activates muscle stem cells (satellite cells) for faster regeneration and repair after injury.
Potential Benefits (Based on Research) Increased endurance and exercise capacity, Support for weight loss and reduced fat accumulation, Faster muscle recovery and repair, and Improved metabolic health and insulin sensitivity.
Status & Availability
Research Compound:
Primarily sold by research chemical suppliers for R&D, often labeled "not for human consumption".
Not FDA Approved:
Not approved for clinical use in humans, with human trials ongoing or planned to assess safety and efficacy.
In essence, SLU-PP-332 targets cellular energy pathways to deliver metabolic and performance benefits similar to exercise, making it a significant area of interest in metabolic and longevity research.
